Connect with us

Health

New FDA-Approved Test Offers a Simpler Way to Screen for Colon Cancer

Published

on

The fight against colorectal cancer (CRC), the second biggest cause of cancer deaths, has gained a significant advantage with the recent Food and Drug Administration (FDA) approval of a revolutionary blood test. California-based Guardant Health’s Shield is the first-ever blood test aimed at primary screening for CRC and is also deemed suitable for Medicare coverage.

This innovative procedure was given the green light following an extensive clinical trial involving 20,000 average-risk adults. The findings, which demonstrated an 83% sensitivity in detecting CRC, was made public in The New England Journal of Medicine in March.

Robert Smith, Ph.D. and senior vice president of Early Cancer Detection Science for the American Cancer Society in Atlanta confirmed that Shield is the lone blood test available for CRC screening. He emphasized the importance of this test, stating, “It compares favorably with other colorectal cancer screening tests,” such as colonoscopy, CT colonography, and stool tests. He also noted the test would likely have greater appeal for those never before screened or not recently screened.

The convenience of this test is another of its merits – it can be performed during a routine doctor’s visit, saving patients the hassle of prepping for procedures or missing work. “It offers the potential to detect colorectal cancer in a person who is non-adherent with screening recommendations, asymptomatic, and willing to get this test based on preference, convenience, or both,” clarifies Smith.

Dr. Shuji Ogino, chief of the Molecular Pathological Epidemiology program at Brigham and Women’s Hospital, echoes Smith’s support. He praises Shield’s “reasonable sensitivity and specificity compared to other blood/stool tests,” and affirms its simplicity and time efficiency when compared to a colonoscopy.

While the potential risks of using Shield on a regular basis have not been extensively studied, Smith suggests that the risks should be minimal. Conversely, he points out that Shield does not offer the same level of colorectal cancer prevention as a colonoscopy does, due to its inability to detect and remove precursor lesions (polyps). However, Smith is optimistic that the benefits of increased screenings will outweigh this drawback.

Stephen Grabelsky, M.D., a hematologist and medical oncologist at the Eugene M. & Christine E. Lynn Cancer Institute at Boca Raton Regional Hospital, also noted that the Shield blood test has a lower sensitivity rate when compared to the Cologard stool test for CRC detection. It is appropriate only for individuals with an average risk for colon cancer, excluding those with a family history of the disorder or a personal history of inflammatory bowel disease.

Currently, the compliance rate for colorectal cancer screenings is significantly low, about 59%, a figure far below the National Colorectal Cancer Roundtable’s target of 80% for eligible individuals. The introduction of the Shield blood test aims to increase the rate of compliance by offering a simpler and less invasive alternative.

The importance of early detection cannot be overstated, as colon cancer has a relative survival rate of 91% when detected early. This figure drops to a mere 14% if the cancer has metastasized to distant parts of the body. As stated by Michael Weist, a spokesperson from Guardant Health, “Early detection is critical. The most effective screening test is the test that gets done.”

The Shield test is expected to be made available commercially by this fall and is suggested for individuals aged 45 and above with an average risk for CRC. Smith advises people interested in the Shield test to discuss both its benefits and limitations with their healthcare provider before making a decision, and to also check if their insurance covers the test. He further notes, “It is important to appreciate that a colorectal cancer screening test that is positive is not complete until the patient has had a colonoscopy. Any non-colonoscopy screening test for colorectal cancer that is positive must be followed up with a colonoscopy.”

Let us know what you think, please share your thoughts in the comments below.

Source

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

Sleep Alert: How One Habit May Increase Heart Attack and Stroke Risk by 26%

Published

on

By

As children, many of us had set bedtimes dictated by our parents, ensuring we got the rest we needed. However, as adults, we have the freedom to choose our own sleep schedules. Despite this autonomy, maintaining a consistent sleep routine might be more beneficial than we realize. A recent study suggests that varying your sleep and wake times could significantly increase your risk of serious cardiovascular issues, such as heart attacks and strokes.

The study, published in the Journal of Epidemiology & Community Health, investigated the sleep patterns of 72,269 individuals aged 40 to 70. These participants were part of the UK Biobank study and wore activity trackers for a week to monitor their sleep. The data collected was used to calculate each participant’s Sleep Regularity Index (SRI) score, which measures the consistency of sleep-wake patterns across consecutive days.

Participants were categorized based on their SRI scores: those scoring over 87 were considered regular sleepers, scores between 72 and 87 indicated moderately irregular sleepers, and scores below 72 were classified as irregular sleepers. Interestingly, regular sleepers were more likely to achieve the recommended seven to nine hours of sleep per night for adults under 65, and seven to eight hours for those over 65.

Over the following eight years, researchers compared these sleep regularity scores with the incidence of cardiovascular events and related deaths. The findings were striking. Irregular sleepers had a 26% increased risk of experiencing major cardiovascular events compared to their regular sleeping counterparts. Even those who were moderately irregular faced an 8% higher risk.

The study authors noted, “Our results suggest that sleep regularity may be more relevant than sufficient sleep duration in modulating MACE [major adverse cardiovascular event] risk.” This implies that even if one gets the recommended amount of sleep, irregular sleep patterns can still pose a significant health risk.

In a press release, the researchers emphasized the importance of sleep consistency in public health guidelines and clinical practices, highlighting its potential impact on cardiovascular health. Lead study author Jean-Philippe Chaput, PhD, from the University of Ottawa, shared with CNN that while exact sleep and wake times aren’t necessary, staying within 30 to 60 minutes of your usual schedule is beneficial.

“Small variations are fine, but consistent sleep patterns improve sleep quality, boost mood and cognitive function, and lower the risk of health issues like heart disease and diabetes,” Chaput explained.

Despite its compelling findings, the study did have limitations. The authors pointed out that it was observational, meaning it could not establish a direct cause-and-effect relationship. Sleep was only monitored for one week, which might not provide a complete picture of long-term patterns. Additionally, the data may not fully represent the broader UK population, and the activity trackers used could not distinguish between quiet wakefulness and sleep or account for napping in the SRI scores.

Overall, this research underscores the importance of maintaining a regular sleep schedule for cardiovascular health, suggesting that consistency in sleep might be as crucial as the amount of sleep itself.

Let us know what you think, please share your thoughts in the comments below.

Source

Continue Reading

Health

Heart Medications That May Protect Your Brain and One to Watch Out For

Published

on

By

As we continue to explore ways to protect our cognitive health as we age, a new study highlights the potential role of common heart medications in reducing dementia risk. While lifestyle changes like diet and exercise have long been recommended, this research suggests that certain medications could provide additional benefits. However, not all heart drugs are created equal, and one in particular might even increase the risk of dementia. Let’s take a closer look at these findings.

Diuretics

Diuretics, commonly known as water pills, are often used to manage blood pressure by helping the body eliminate excess fluid. The study indicates that these medications could also play a role in reducing dementia risk. Researchers suggest that diuretics might “exert antioxidant and neuroprotective effects” by preserving potassium or uric acid levels. This protective mechanism could contribute to the lower risk of dementia observed in those who use these drugs long-term.

Renin-Angiotensin System (RAS)-Acting Agents

RAS-acting agents are another class of drugs used to treat high blood pressure. According to the study, these medications may specifically help ward off Alzheimer’s disease by safeguarding certain brain mechanisms. The researchers noted, “We can see a clear link between long-term use—five years or more—of these drugs and reduced risk of dementia in older age.” This suggests that maintaining consistent use of these medications could be beneficial for cognitive health.

Cholesterol-Lowering Drugs

Cholesterol-lowering medications, such as statins, are known for their role in managing heart health. The study found that these drugs might also lower the risk of dementia by preventing plaque buildup in blood vessels, which can impede blood flow to the brain. The combination of cholesterol-lowering drugs and blood pressure medications was particularly effective, further reducing dementia risk. “Previous studies have focused on individual drugs and specific patient groups but in this study, we take a broader approach,” explained Alexandra Wennberg, PhD, co-lead study author.

Combination Therapy

The study highlights the benefits of using a combination of the aforementioned drugs. Individuals taking two to three different treatments experienced a significant reduction in dementia risk, with a decrease of 27 to 30 percent. This suggests that a multi-faceted approach to managing heart health could also support cognitive well-being.

Antiplatelet Drugs

While many heart medications show promise in reducing dementia risk, antiplatelet drugs, such as aspirin, may have the opposite effect. These medications are used to prevent strokes by stopping platelets from clumping together. However, the study found that they might increase the risk of microbleeds in the brain, which is linked to cognitive decline. People taking these drugs had a 13 to 25 percent higher risk of developing dementia.

This study sheds light on the complex relationship between heart medications and dementia risk. While certain drugs show promise in reducing the likelihood of cognitive decline, others may pose a risk. It’s important for individuals to consult with healthcare professionals to determine the best course of action for both heart and brain health.

Let us know what you think, please share your thoughts in the comments below.

Source

Continue Reading

Health

Expert Reveals Top 3 Gut Health Mistakes to Avoid

Published

on

By

The intricate world of gut health is gaining increasing attention as researchers uncover its profound influence on our overall well-being. The gut microbiome, a complex ecosystem of over 100 trillion microbes, including bacteria, fungi, yeast, and viruses, plays a crucial role in how our body functions. This collection of microorganisms is so influential that experts often refer to it as the “second brain,” according to registered dietitian Kristian Kirkpatrick, RD.

Endocrinologist and researcher Max Nieuwdorp, PhD, emphasizes the importance of maintaining a healthy gut microbiome for balanced hormone levels. In his book, *The Power of Hormones*, Nieuwdorp details how gut microbes are instrumental in the release and production of hormones, impacting critical processes like metabolism and mood. He shares three key things to avoid for optimal gut health.

One major dietary change Nieuwdorp recommends is reducing red meat consumption. During an interview with Business Insider, he explained that red meat can alter the gut microbiome’s composition by producing “dangerous” metabolites during digestion.

“I try to not eat meat every day,” Nieuwdorp said.

While protein is essential, a diet heavily reliant on red meat can increase the risk of various health issues, including diabetes, heart disease, stroke, and colorectal cancer. Red meat is also known for its high cholesterol, saturated fats, and sodium content.

Ultra-processed foods are another group Nieuwdorp steers clear of. These include sweetened breakfast cereals, processed meats, sodas, and some frozen meals. Instead, he opts for fresh foods without preservatives or additives.

Gastroenterologist Preeya Goyal, MD, highlights the dangers of ultra-processed foods, noting, “Ultra-processed foods contain large quantities of saturated fat and trans-fat, added sugar, salt, and food additives that seriously affect the gut and physical health.”

Finally, Nieuwdorp is cautious about antibiotics, using them only when absolutely necessary. He warns, “They drive dysbiosis in the gut.”

Dysbiosis, as explained by the Cleveland Clinic, is an imbalance in the diversity of gut microorganisms, making individuals more susceptible to infections and disrupting essential functions normally provided by a healthy microbiome. This imbalance can also adversely affect hormone function.

By avoiding these common pitfalls, Nieuwdorp advocates for a balanced gut microbiome, which in turn supports overall health and well-being.

Let us know what you think, please share your thoughts in the comments below.

Source

Continue Reading

Trending

" "